Philanthropic Giving: Upsetting The Apple Cart Or Plugging The Pipeline?
Executive Summary
Facebook inventor Mark Zuckerberg grabbed headlines across the globe this year when he and wife Priscilla Chan announced a $3bn initiative with one momentous goal: to cure all disease. The initiative has released few details, but the pledge of $3bn from a technology business owner into disease research has sparked curiosity and concern.
You may also be interested in...
GSK And Google To Invest £540m In UK-Headquartered Bioelectronics JV
GlaxoSmithKline is teaming up with the company formerly known as Google Life Sciences to create bioelectronic therapeutics, and hopes to have a product ready for market within seven years.
Where Will Technology Take Pharma In 2016?
Non-traditional healthcare partnerships are on the increase, including collaborative deals between big pharmas and technology giants such as Apple Inc. and Google. But what changes could these business partnerships – which have increased over the past few years – have in the long-term on the pharmaceutical and biotech industry?
Gates Commits $89m To Novavax After Maternal RSV Vaccine Success
Now that Novavax Inc.'s respiratory syncytial virus (RSV) vaccine has succeeded in a Phase II clinical trial in pregnant women, the Bill & Melinda Gates Foundation has committed up to $89m to help the company fund a massive Phase III trial that will include sites in developing countries.